Comment on: "Hemodynamic comparison of intravenous push diltiazem versus metoprolol for atrial fibrillation rate control"

Am J Emerg Med. 2021 Jul:45:655-656. doi: 10.1016/j.ajem.2020.10.076. Epub 2020 Nov 6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Arrhythmia Agents / therapeutic use
  • Atrial Fibrillation* / drug therapy
  • Diltiazem* / pharmacology
  • Hemodynamics / drug effects
  • Humans
  • Metoprolol

Substances

  • Anti-Arrhythmia Agents
  • Diltiazem
  • Metoprolol